News & Updates
Showing Neurology articles
Showing
Show Multimedia Only

AXS-05 delays relapse of Alzheimer's disease agitation
22 Apr 2025
byElaine Soliven
Treatment with AXS-05 significantly delayed the time to relapse of agitation in patients with Alzheimer’s disease (AD) compared with placebo, according to the phase III ACCORD-2 trial presented at AAN 2025.
22 Apr 2025







